BioAffinity regains Nasdaq compliance for stock and warrants

BioAffinity Technologies (NASDAQ: BIAF, BIAFW) announced it has received written notice from the Nasdaq Stock Market LLC confirming the company has regained compliance with Nasdaq's applicable listing requirements.

In a letter dated September 8, 2026, Nasdaq confirmed that the company has satisfied Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, and Listing Rule 5560(a), which establishes listing requirements applicable to rights and warrants. A previously scheduled hearing before the Nasdaq Hearings Panel has been cancelled as a result.

The company's common stock and warrants will continue to be listed and traded on the Nasdaq Capital Market under the symbols BIAF and BIAFW, subject to continued compliance with all applicable Nasdaq listing requirements.

"We are pleased to have regained full compliance with Nasdaq's listing standards," said Maria Zannes, President and Chief Executive Officer of BioAffinity Technologies.

You May Also Be Interested In

• Freedom Broker Downgrades Nucor (NUE) to Hold, 'Guides Conservative Earnings Yet Again'
• Gauzy wins court approval to resolve $61M in debt via creditor vote
• Grok releases Voice Transcribe 2.0 with improved accuracy